U.S. Immunoassay Analyzers Market Size & Outlook
U.S. immunoassay analyzers market, 2016-2028 (US$M)
Related Markets
U.S. immunoassay analyzers market highlights
- The U.S. immunoassay analyzers market generated a revenue of USD 8,531.5 million in 2021 and is expected to reach USD 12,419.3 million by 2028.
- The U.S. market is expected to grow at a CAGR of 5.5% from 2022 to 2028.
- In terms of segment, reagents & kits was the largest revenue generating product in 2021.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Immunoassay analyzers market data book summary
| Market revenue in 2021 | USD 8,531.5 million |
| Market revenue in 2028 | USD 12,419.3 million |
| Growth rate | 5.5% (CAGR from 2021 to 2028) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.7% of the global immunoassay analyzers market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. immunoassay analyzers market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,583.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay Analyzers Market Scope
Immunoassay Analyzers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. immunoassay analyzers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 65.7% in 2021. Horizon Databook has segmented the U.S. immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
The growth in this region can primarily be attributed to high adoption of technologically advanced immunoassay products, favorable reimbursement scenario, and an increase in prevalence of chronic & infectious diseases.
The ongoing global pandemic has further propelled the growth of immunoassay analyzers market. According to the CDC (Centers for Disease Control and Prevention), COVID-19 affected about 114.6 million Americans, while about 97.1 million had symptomatic illnesses, and 5.6 million were admitted to hospitals between February 2020 and March 2021.
Chronic diseases are generally incurable and ongoing and are one of the leading reasons for high healthcare expenditure in the U.S.; USD 3.8 trillion annual healthcare expenditure. According to the CDC, 6 in 10 adults are suffering from chronic diseases and 4 in 10 suffer from two or more types of chronic diseases leading to death or disability.
Reasons to subscribe to U.S. immunoassay analyzers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. immunoassay analyzers market databook
-
Our clientele includes a mix of immunoassay analyzers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into U.S. immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. immunoassay analyzers market size, by product, 2016-2028 (US$M)
U.S. Immunoassay Analyzers Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
